PRTN3 and rheumatoid arthritis: Evidence suggests, that human fibrinogen and α-enolase (targeted by ACPA in RA) are substrates for PPAD, and that antibodies against citrullinated α-enolase from P. gingivalis cross-react with human anti-α-enolase antibodies (187).